Stay updated with breaking news from Mrns. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
and run into malcolm kenyatta, who s a fellow pennsylvanian. and it was great to see him. and you know, the campaign has people like him talking about what people are actually feeling out there, i think that s going to be very, very helpful. you can give people statistics, you can give people all sorts of stuff, but we have to have real conversations about how are these things affecting you at home. so i thought, lot of surprises for me, lot of fun in one hallway running into two of my old friends. i m going to see you in not too many hours. we re going to do this all over again. get some sleep, my friend. a surprise from the supreme court today a ruling in favor of common sense. all the justices except thomas joined in favor in the case of preventing domestic abusers from having guns. chief justice roberts in the majority opinion wrote, quote, the laws confirm what common sense suggests, when an individual poses a clear threat of physical violence to another, the ....
Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) is scheduled to be issuing its quarterly earnings data before the market opens on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.68) per share for the quarter. Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) last issued its earnings results on Tuesday, March 5th. The […] ....
Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) will be posting its quarterly earnings results before the market opens on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.68) per share for the quarter. Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) last released its quarterly earnings data on Tuesday, March 5th. The biopharmaceutical […] ....
Mach 1 Financial Group LLC reduced its stake in Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Free Report) by 35.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 43,828 shares of the biopharmaceutical company’s stock after selling 24,375 shares during the period. […] ....
Mach 1 Financial Group LLC lessened its stake in shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Free Report) by 35.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 43,828 shares of the biopharmaceutical company’s stock after selling 24,375 shares during the period. Mach 1 […] ....